The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance
抗疟药MMV688533具有单剂量治愈的潜力,且对恶性疟原虫的耐药性具有很高的屏障。
期刊:Science Translational Medicine
影响因子:15.8
doi:10.1126/scitranslmed.abg6013
James M Murithi,Cécile Pascal,Jade Bath,Xavier Boulenc,Nina F Gnädig,Charisse Flerida A Pasaje,Kelly Rubiano,Tomas Yeo,Sachel Mok,Sylvie Klieber,Paul Desert,María Belén Jiménez-Díaz,Jutta Marfurt,Mélanie Rouillier,Mohammed H Cherkaoui-Rbati,Nathalie Gobeau,Sergio Wittlin,Anne-Catrin Uhlemann,Ric N Price,Grennady Wirjanata,Rintis Noviyanti,Patrick Tumwebaze,Roland A Cooper,Philip J Rosenthal,Laura M Sanz,Francisco Javier Gamo,Jayan Joseph,Shivendra Singh,Sridevi Bashyam,Jean Michel Augereau,Elie Giraud,Tanguy Bozec,Thierry Vermat,Gilles Tuffal,Jean-Michel Guillon,Jérôme Menegotto,Laurent Sallé,Guillaume Louit,Marie-José Cabanis,Marie Françoise Nicolas,Michel Doubovetzky,Rita Merino,Nadir Bessila,Iñigo Angulo-Barturen,Delphine Baud,Lidiya Bebrevska,Fanny Escudié,Jacquin C Niles,Benjamin Blasco,Simon Campbell,Gilles Courtemanche,Laurent Fraisse,Alain Pellet,David A Fidock,Didier Leroy